ono-4053
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2011 (NCT01379586)
Timeline
Indications
Mechanism of action
- Prostaglandin D2 synthaseINHIBITOR
PTGDS inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ono-4053
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01909986 | Phase 1 | Oct 1, 2013 | Ono Pharmaceuticals |
| NCT01748344 | Phase 2 | Nov 1, 2012 | Ono Pharmaceuticals |
| NCT01537172 | Phase 1 | Jan 1, 2012 | Ono Pharmaceuticals |
| NCT01379586 | Phase 1 | Jun 1, 2011 | Ono Pharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 4 | 4 | 2 | 2011 |
1 organizations
Page 1 / 1